In our retrospective review of patients with pT0–T2 ER+ HER2− breast cancer with 3–5 positive lymph nodes who underwent adjuvant chemotherapy, endocrine therapy, and radiation treatment, we found no difference in OS between patients who underwent SLNB and ALND. This evidence concerns the gene ESR1 and breast carcinoma.